Pain, Substance Use Disorder, and Behavioral Health

The Pain, Substance Use Disorder, and Behavioral Health team aims to answer questions regarding the impact of COVID-19 on pain, substance use, and mood. These conditions are impacted by isolation, and the amplification of Long COVID symptoms may have a significant impact on their functional status. The team works on the COVID-19's impact on stigma and health disparities for patients with pain, substance use disorder, and co-morbid mental health diagnoses.

 

 

First Time Users: To get started with N3C and gain access to the N3C Data Enclave, please view the Researcher Essentials webpage.
For Questions or Comments: Please access the N3C Support Desk and click on "Request Domain Team Support".

Google Group Email
n3c-dt-pain@googlegroups.com

Leadership

Meredith Adams MD, MS, FASA, FAMIA

Wake Forest School of Medicine 

Elaine Hill Headshot

University of Rochester Medical Center

Robert Hurley, MD, PhD

Wake Forest Baptist Health

Umit Topaloglu Headshot

Wake Forest University

Jaylin Clark, PhD

Wake Forest Baptist Health